In Vitro/In Vivo Evaluation of Dexamethasone - PAMAM Dendrimer Complexes for Retinal Drug Delivery

Journal of Pharmaceutical Sciences

Volumn 104, Issue 11, 2015, Pages 3814-3823

  Yavuz, Burçin ^a   Pehlivan, Sibel Bozdaʇ ^a   Vural, Imran ^a   Ünlü, Nurşen ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

cell culture; dendrimers; drug delivery systems; drug transport; nanotechnology; ophthalmic drug delivery; permeability

Indexed keywords

DENDRIMER; DEXAMETHASONE; POLYAMIDOAMINE; ANTIINFLAMMATORY AGENT; PAMAM STARBURST;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APPARENT PERMEABILITY; ARTICLE; CELL MEMBRANE PERMEABILITY; COMPLEX FORMATION; CONTROLLED STUDY; CORNEA; CYTOTOXICITY TEST; DRUG ABSORPTION; DRUG ACCUMULATION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG TRANSPORT; EX VIVO STUDY; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; IONTOPHORESIS; METHYL THIAZOLYL TETRAZOLIUM ASSAY; MOLECULAR WEIGHT; NONHUMAN; OCULAR TISSUE; RAT; RETINA; RETINAL THICKNESS; SCLERA; SPRAGUE DAWLEY RAT; TANDEM MASS SPECTROMETRY; TISSUE DISTRIBUTION; ANIMAL; CHEMISTRY; METABOLISM; PERMEABILITY; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; DENDRIMERS; DEXAMETHASONE; DRUG DELIVERY SYSTEMS; PERMEABILITY; RATS, SPRAGUE-DAWLEY; RETINA;

EID: 84942802035     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.24588     Document Type: Article

References (48)

1. Nagarwal RC, Kant S, Singh PN, Maiti P, Pandit JK,. 2009. Polymeric nanoparticulate system: A potential approach for ocular drug delivery. J Control Release 136 (1): 2-13.
2. Gaudana R, Jwala J, Boddu SHS, Mitra AK,. 2009. Recent perspectives in ocular drug delivery. Pharm Res 26 (5): 1197-1216.
3. Lang JC,. 1995. Ocular drug-delivery conventional ocular formulations. Adv Drug Deliv Rev 16 (1): 39-43.
4. Ranta VP, Mannermaa E, Lummepuro K, Subrizi A, Laukkanen A, Antopolsky M, Murtomaki L, Hornof M, Urtti A,. 2010. Barrier analysis of periocular drug delivery to the posterior segment. J Control Release 148 (1): 42-48.
5. Eljarrat-Binstock E, Pe'er J, Domb AJ,. 2010. New techniques for drug delivery to the posterior eye segment. Pharm Res 27 (4): 530-543.
6. Ranta VP, Urtti A,. 2006. Transscleral drug delivery to the posterior eye: Prospects of pharmacokinetic modeling. Adv Drug Deliv Rev 58 (11): 1164-1181.
7. Del Amo EM, Urtti A,. 2008. Current and future ophthalmic drug delivery systems. A shift to the posterior segment. Drug Discov Today 13 (3-4): 135-143.
8. Saaddine JB, Honeycutt AA, Narayan KMV, Zhang XZ, Klein R, Boyle JP,. 2008. Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus United States, 2005-2050. Arch Ophthalmol-Chic 126 (12): 1740-1747.
9. Adamis AP, Berman AJ,. 2008. Immunological mechanisms in the pathogenesis of diahetic retinopathy. Semin Immunopathol 30 (2): 65-84.
10. Avery RL, Pearlman J, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ, Wendel R, Patel A,. 2006. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 113 (10): 1695-1705.
11. Ayalasomayajula SP, Kompella UB,. 2004. Retinal delivery of celecoxib is several-fold higher following subconjunctival administration compared to systemic administration. Pharm Res 21 (10): 1797-1804.
12. Clark AF, Yorio T,. 2003. Ophthalmic drug discovery. Nat Rev Drug Discov 2 (6): 448-459.
13. Quintana A, Raczka E, Piehler L, Lee I, Myc A, Majoros I, Patri AK, Thomas T, Mule J, Baker JR,. 2002. Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor. Pharm Res 19 (9): 1310-1316.
14. Kaminskas LM, Boyd BJ, Porter CJH,. 2011. Dendrimer pharmacokinetics: The effect of size, structure and surface characteristics on ADME properties. Nanomedicine 6 (6): 1063-1084.
15. Jain K, Kesharwani P, Gupta U, Jain NK,. 2010. Dendrimer toxicity: Let's meet the challenge. Int J Pharm 394: 122-142.
16. Yavuz B, Pehlivan SB, Unlu N,. 2013. Dendrimeric systems and their applications in ocular drug delivery. Sci World J. 732340, 1-13.
17. Thakur A, Kadam R, Kompella UB,. 2011. Trabecular meshwork and lens partitioning of corticosteroids: Implications for elevated intraocular pressure and cataracts. Arch Ophthalmol 129 (7): 914-920.
18. Kim SJ, Toma H, Shah R, Kompella UB, Vooturi SK, Sheng JS,. 2014. The safety, pharmacokinetics, and efficacy of intraocular celecoxib. Invest Ophthalmol Vis Sci 55 (3): 1409-1418.
19. Moore TW, Shangraw RF, Habib Y,. 1996. Dissolution calibrator tablets: A recommendation for new calibrator tablets to replace both current USP calibrator tablets. Pharmacopeial Forum 22 (3): 2423-2428.
20. Bozdag S, Capan Y, Vural I, Dalkara T, Dogan AL, Guc D, Hincal AA, Deluca PP,. 2004. In vitro cytotoxicity of mitoxantrone-incorporated albumin microspheres on acute promyelocytic leukaemia cells. J Microencapsul 21 (7): 751-760.
21. Cui HS, Hayasaka S, Zhang XY, Hayasaka Y, Chi ZL, Zheng LS,. 2007. Effect of berberine on barrier function in a human retinal pigment epithelial cell line. Jpn J Ophthalmol 51 (1): 64-67.
22. Yavuz B, Bilensoy E, Vural I, Sumnu M,. 2010. Alternative oral exemestane formulation: Improved dissolution and permeation. Int J Pharm 398 (1-2): 137-145.
23. Popescu MC, Filip D, Vasile C, Cruz C, Rueff JM, Marcos M, Serrano JL, Singurel G,. 2006. Characterization by Fourier transform infrared spectroscopy (FT-IR) and 2D IR correlation spectroscopy of PAMAM dendrimer. J Phys Chem B 110 (29): 14198-14211.
24. Clogston JD, Patri AK,. 2011. Zeta potential measurement. In Characterization of nanoparticles intended for drug delivery methods in molecular biology;, McNeil SE, Ed. Humana Press, pp New York, 63-70.
25. Amrite AC, Kompella UB,. 2005. Size-dependent disposition of nanoparticles and microparticles following subconjunctival administration. J Pharm Pharmacol 57 (12): 1555-1563.
26. Bourges JL, Gautier SE, Delie F, Bejjani RA, Jeanny JC, Gurny R, BenEzra D, Behar-Cohen FF,. 2003. Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles. Invest Ophthalmol Vis Sci 44 (8): 3562-3569.
27. Reddy IK, Ganesan MG,. 1995. Ocular theraputics and drug delivery: An overview. In Ocular theraputics and drug delivery;, Reddy IK, Ed. CRS Press, Boca Raton, FL.
28. Vandamme TF, Brobeck L,. 2005. Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide. J Control Release 102 (1): 23-38.
29. Patri AK, Kukowska-Latallo JF, Baker JR,. 2005. Targeted drug delivery with dendrimers: Comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex. Adv Drug Deliv Rev 57 (15): 2203-2214.
30. Yang H, Kao WYJ,. 2006. Dendrimers for pharmaceutical and biomedical applications. J Biomat Sci-Polym E 17 (1-2): 3-19.
31. (TM) dendrimers. J Biomed Mater Res 30 (1): 53-65.
32. Jevprasesphant R, Penny J, Attwood D, McKeown NB, D'Emanuele A,. 2003. Engineering of dendrimer surfaces to enhance transepithelial transport and reduce cytotoxicity. Pharm Res 20 (10): 1543-1550.
33. Chen HT, Neerman MF, Parrish AR, Simanek EE,. 2004. Cytotoxicity, hemolysis, and acute in vivo toxicity of dendrimers based on melamine, candidate vehicles for drug delivery. J Am Chem Soc 126 (32): 10044-10048.
34. Fischer D, Li Y, Ahlemeyer B, Krieglstein J, Kissel T,. 2003. In vitro cytotoxicity testing of polycations: Influence of polymer structure on cell viability and hemolysis. Biomaterials 24 (7): 1121-1131.
35. Jain NK, Gupta U,. 2008. Application of dendrimer-drug complexation in the enhancement of drug solubility and bioavailability. Expert Opin Drug Met 4 (8): 1035-1052.
36. El-Sayed M, Ginski M, Rhodes C, Ghandehari H,. 2002. Transepithelial transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers. J Control Release 81 (3): 355-365.
37. Kitchens KM, Foraker AB, Kolhatkar RB, Swaan PW, Ghandehari H,. 2007. Endocytosis and interaction of poly (amidoamine) dendrimers with Caco-2 cells. Pharm Res 24 (11): 2138-2145.
38. Tajarobi F, El-Sayed M, Rege BD, Polli JE, Ghandehari H,. 2001. Transport of poly amidoamine dendrimers across Madin-Darby canine kidney cells. Int J Pharm 215 (1-2): 263-267.
39. Kitchens KM, Kolhatkar RB, Swaan PW, Eddington ND, Ghandehari H,. 2006. Transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers: Influence of size, charge and fluorescent labeling. Pharm Res 23 (12): 2818-2826.
40. Wen H, Hao JS, Li SK,. 2013. Characterization of human sclera barrier properties for transscleral delivery of bevacizumab and ranibizumab. J Pharm Sci 102 (3): 892-903.
41. Sunkara G, Kompella UB,. 2003. Membrane transport processes in the eye. In Ophthalmic drug delivery systems;, Mitra AK, Ed. 2nd ed. New York: Marcel Dekker Inc., pp 13-58.
42. Pitkanen L, Ranta VP, Moilanen H, Urtti A,. 2005. Permeability of retinal pigment epithelium: Effects of permeant molecular weight and lipophilicity. Invest Ophthalmol Vis Sci 46 (2): 641-646.
43. Maurice DM, Polgar J,. 1977. Diffusion across the sclera. Exp Eye Res 25 (6): 577-582.
44. Prausnitz MR, Noonan JS,. 1998. Permeability of cornea, sclera, and conjunctiva: A literature analysis for drug delivery to the eye. J Pharm Sci 87 (12): 1479-1488.
45. Missel P, Chastain J, Mitra A, Kompella U, Kansara V, Duvvuri S, Amrite A, Cheruvu N,. 2010. In vitro transport and partitioning of AL-4940, active metabolite of angiostatic agent anecortave acetate, in ocular tissues of the posterior segment. J Ocul Pharmacol Ther 26 (2): 137-145.
46. Bessonova J, Meyer-Lindenberg A, Baumer W,., Kietzmann M, 2011. Tissue distribution of dexamethasone in feline ocular structures following single topical application of dexamethasone as an ointment or suspension. Veterinary Ophthalmology 14 (2): 109-113-378.
47. Tanito M, Hara K, Takai Y, Matsuoka Y, Nishimura N, Jansook P, Loftsson T, Stefansson E, Ohira A,. 2011. Topical dexamethasone-cyclodextrin microparticle eye drops for diabetic macular edema. Invest Ophthalmol Vis Sci 52 (11): 7944-7948.
48. Souza JG, Dias K, Silva SAM, de Rezende LCD, Rocha EM, Emery FS, Lopez RFV,. 2015. Transcorneal iontophoresis of dendrimers: PAMAM corneal penetration and dexamethasone delivery. J Control Release 200: 115-124.